INHIBITION OF COX-2 AND INDUCTION OF APOPTOSIS: Two Determinants of Nonsteroidal Anti-Inflammatory Drugs' Chemopreventive Efficacies in Mouse Lung Tumorigenesis

References

• Vane JR, Botting RM:Mechanism of action of antiinfl ammatory drugs. Int J Tissue React. 1998;20:3–15.
   Google Scholar
• Smalley WE, DuBois RN:Colorectal cancer and nonsteroidal anti-infl ammatory drugs. Adv Pharmacol. 1997;39:1–20.
   Google Scholar
• Schreinemachers DM, Everson RB:Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994;5:138–146.
   Google Scholar
• Rubio CA:Antitumoral activity of indomethacin on experimental esophageal tumors. J Natl Cancer Inst. 1984;72:705–707.
   Google Scholar
• Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, Hayashi Y. Effect of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxypropyl) amine. Carcinogenesis. 1990;11:393–395.
   Google Scholar
• Carter CA, Milholland RJ, Shea W, Ip MM:Effect of the prostaglandin synth etase inhibitor indomethacin on 7, 12-dimethylbenz(a) anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res. 1983;43:3559–3562.
   Google Scholar
• Verma AJ, Ashendel CL, Boutwell RK:Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tu mor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1980;40:308–315.
   Google Scholar
• Tanaka T, Nishikawa A, Mori Y, Morishita Y, Mori H:Inhibitory effects of non-steroidal anti-infl ammatory drugs, piroxicam and indomethacin, on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats. Cancer Lett. 1989;48:177–182.
   Google Scholar
• Rao AR, Hussain SP:Modulation of methylcholanthrene-induced carcinogenesis in the uterine cervix of mouse by indomethacin. Cancer Lett. 1988;43:15–19.
   Google Scholar
• Jalbert G, Castonguay A:Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett. 1992;66:21–28.
   Google Scholar
• Pepin P, Bouchard L, Nicole P, Castonguay A:Effects of sulindac and oltipraz on the tu morigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis. 1992;13:341–348.
   Google Scholar
• Duperron C, Castonguay A:Ch emopreventive effi cacies of aspirin and sulindac against lung tu morigenesis in A/J mice. Carcinogenesis. 1997;18:1001–1006.
   Google Scholar
• Rioux N, Castonguay A:Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res 1998;58:5354–5360.
   Google Scholar
• Crofford LJ:COX-1 and COX-2 tissue expression:implications and predictions. J Rheumatol. 1997;49(24S):15-19.
   Google Scholar
• Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Isakson P:Distribution of COX-1 and COX-2 in normal and infl amed tissues. Adv Exp Med Biol. 1997;400A:167-170.
   Google Scholar
• Hwang D, Scollard D, Byrne J, Levine E:Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 1998;90:455–460.
   Google Scholar
• Bauer AK, Dwyer-Nield LD, Malkinson AM:High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis 2000;21:543–550.
   Google Scholar
• Wardlaw SA, March TH, Belinsky SA:Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. Carcinogenesis 2000;21:1371–1377.
   Google Scholar
• Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM:Suppression of intestinal polyposis in APC 716 knockout mice by inhibition of cyclooxygenase-2 (Cox-2). Cell. 1996;87:803–809.
   Google Scholar
• Shiff SJ, Koutsos MI, Qiao L, Rigas B:Nonsteroidal antiinfl ammatory drugs inhibit the proliferation of colon adenocarcinoma cells:effects on cell cycle and apoptosis. Exp Cell Res. 1996;222:179–188.
   Google Scholar
• Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B:Effects of nonsteroidal anti-infl ammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by prostaglandin-independent pathway. Biochem Pharmacol. 1996;52:237–245.
   Google Scholar
• Chan TA, Morin PJ, Vogelstein B, Kinzler KW:Me chanisms underlying nonsteroidal antiinfl ammatory drug-mediated apoptosis. Proc Natl Acad Sci US A. 1998;95:681–686.
   Google Scholar
• You M, Candrian U, Maronpot R, Stoner GD, Anderson MW:Activation of the K-ras protoon cogene in spontaneou sly occurring and chemically-induced lung tumors of the strain A mouse. Proc Natl Acad Sci US A. 1989;86:3070–3074.
   Google Scholar
• Saiki R, Gelfand D, Stoffel S:Primer-directed enzymatic amplifi cation of DNA with a thermostable DNA polymerase. Science. 1988;235:487–491.
   Google Scholar
• Tindall K, Stankowski L:Molecular analysis of spontaneous mutations at the qpt locus in Chinese hamster ovary (AS52) cells. Mutat Res. 1989;220:241–253.
   Google Scholar
• Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ:Inhibition of cyclooxygenase:a novel approach to cancer prevention. Proc Soc Exp Biol Med. 1997;216:201–210.
   Google Scholar
• Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V, Reddy BS:Ch emoprevention of carcinogenesis by sulindac, a nonsteroidal anti-infl ammatory agent. Cancer Res. 1995;55:1464–1472.
   Google Scholar
• Tsujii M, DuBois RN:Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell. 1995;83:493–501.
   Google Scholar
• Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T:Increased expression of cyclooxygenase 2 occurs frequently in hu man lung cancers, specifi cally in adenocarcinomas. Cancer Res. 1998;58:3761–3764.
   Google Scholar
• DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD:G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res. 1996;56:733–737.
   Google Scholar
• Sharma VK, Bologa RM, Li B, Xu GP, Lagman M, Hiscock W, Mouradian J, Wang J, Serur D, Rao VK, Suthanthiran M:Molecular executors of cell death —differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation. 1996;62:1860–1866.
   Google Scholar
• Jia L, Macey MG, Yin Y, Newland AC, Kelsey SM:Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood. 1999;93:2353–2359.
   Google Scholar
• Bhuiyan ZA, Yatsuki H, Sasaguri T, Joh K, Soejima H, Zhu X, Hatada I, Morisaki H, Morisaki T, Mukai T:Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome. Hum Genet. 1999;104:205–210.
   Google Scholar
• Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, Xiong Y:Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci US A. 1998;95:1392–1397.
   Google Scholar
• De Smedt V, Crozet N, Jessus C:In vitro binding of free cdc2 and raf kinase to membrane vesicles:a possible new regulatory mechanism for cdc2 kinase activation in Xenopus oocyte. Microsc Res Tech. 1999;45:13–30.
   Google Scholar
• Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, De Cosse JJ, Bertagnolli MM:Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 1996;56:2556–2560.
   Google Scholar